Telomeres, senescence and cellular radiation response

Cellular and Molecular Life Sciences

Volumn 53, Issue 7, 1997, Pages 568-575

  Crompton, N E A ^a  

^a CH 5232   (Switzerland)

Author keywords

Ageing; Programmed response; Radiation; Senescence; Telomerase; Telomeres

Indexed keywords

POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PRIMER RNA; TELOMERASE;

AGING; APOPTOSIS; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL DIVISION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL PROTECTION; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; IRRADIATION; RADIATION INJURY; RADIATION INJURY REPAIR; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE;

ANIMALS; APOPTOSIS; CELL AGING; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPLICATION; ENZYME ACTIVATION; ONCOGENIC VIRUSES; RADIATION, IONIZING; SIGNAL TRANSDUCTION; TELOMERASE; TELOMERE;

EID: 0030921553     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050073     Document Type: Review

References (105)

1. McClintock B. (1984) The significance of responses of the genome to challenge. Science 226: 792-801
2. Wiener N. (1948) Cybernetics or Control and Communication in the Animal and Machine. MIT Press, Cambridge, USA
3. Lerner A. Y. (1972) Fundamentals of Cybernetics. Plenum. New York
4. McClintock B. (1941) The stability of broken ends of chromosomes in Zea mays. Genetics 26: 234-284
5. Wright W. E. and Shay J. W. (1996) Mechanisms of escaping senescence in human diploid cells. In: Cellular Aging and Cell Death, pp. 153-166, Holbrook N. J., Martin G. R. and Lockshin R. A. (eds), John Wiley & Sons, New York
6. Jacobson M. D., Weil M. and Raff M. C. (1997) Programmed cell death in animal development. Cell 88: 347-354
7. Crompton N. E. A., Sigg M. and Jaussi R. (1994) Genome lability in radiation-induced transformants of C3H 10T1 2 mouse fibroblasts. Radial. Res. 138: S105-S108
8. Joshi G. P., Nelson W. J., Revell S. H. and Shaw C. A. (1982) X-ray-induced chromosome damage in live mammalian cells, and improved measurements of its effects on their colony-forming ability. Int. J. Radiat. Res. 41: 161-181
9. Crompton N. E. A. and Ozsahin M. (1997) A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface marker assessment of cytotoxicity. Radiat. Res. 147: 55-60
10. de Lange T. (1994) Activation of telomerase in a human tumour. Proc. Natl Acad. Sci. USA 91: 2882-2885
11. Stein G. H. and Dulic V. (1995) Origins of G1 arrest in senescent human fibroblasts. Bioessays 17: 537-543
12. Crompton N. E. A. and Saydan N. (1994) Control of the cell cycle. J. Neurooncol. 22: 255-259
13. Walters R. A., Gurley L. R. and Tobey R.A. (1974) Effects of caffeine on radiation-induced phenomena associated with cell-cycle traverse of mammalian cells. Biophys. J. 14: 99-118
14. Crompton N. E. A., Hain J., Jaussi R. and Burkart W. (1993) Staurosporine and radiation induced G2 cell cycle blocks are equally released by caffeine. Radial. Res. 135: 372-379
15. Hain J., Crompton N. E. A., Burkart W. and Jaussi R. (1993) Caffeine release of radiation induced S and G2 phase arrest in V79 hamster cells: Increase of histone mRNA levels and p34cdc2 activation. Cancer Res. 53: 1507-1510
16. Lane D. P. (1992) p53. guardian of the genome. Nature 358: 15-16
17. Nagasawa H., Keng P., Harley R., Dahlberg W. and Little J. B. (1994) Relationship between gamma ray-induced G2 M delay and cellular radiosensitivity. Int. J. Radiat. Biol. 66: 373-379
18. Sandell L. L. and Zakian V. A. (1993) Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 75: 729-739
19. Bae I., Fan S., Bhatia K., Kohn K. W., Fornace A. J. and O'Connor P. M. (1995) Relationships between G1 arrest and stability of the p53 and p21 proteins following gamma irradiation of human lymphoma cells. Cancer Res. 55: 2387-2393
20. Dulic V., Kaufmann W. K., Wilson S. J., Tlsty T. D., Lees E., Harper J. W. et al. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023
21. Mueller H. J. (1938) The remaking of chromosomes. Collect. Net 13: 181-198
22. Mueller H. J. and Herskowitz I. H. (1954) Concerning the healing of chromosome ends produced by breakage in Drosophila melanogaster. Am. Nat. 88: 177-208
23. McClintock B. (1942) The fusion of broken ends of chromosomes following nuclear fusion. Proc. Natl Acad. Sci. USA 28: 458-463
24. Greider C. W. (1991) Chromosome first aid. Cell 67: 645-647
25. Silver A. and Cox R. (1993) Telomere-like DNA polymorphisms associated with genetic predisposition to acute myeloid leukemia in irradiated CBA mice. Proc. Natl Acad. Sci. USA 90: 1407-1410
26. Vaziri H., Dragowska W., Allsopp R. C., Thomas T. E., Harley C.B. and Lansdorp P.M. (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl Acad. Sci. USA 91: 9857-9860
27. Zakian V. A. (1989) Structure and function of telomeres Annu. Rev. Genet. 23: 579-604
28. Brown W. R. A., MacKinnon P. J., Villasante A., Spurr N., Buckle V. J. and Dobson M. J. (1990) Structure and polymorphism of human telomere-associated DNA. Cell 63: 119-132
29. Ijdo J. W., Baldini A., Ward D. C., Reeders S. T. and Wells R. A. (1991) Origin of human chromosome 2: an ancestral telomere-telomere fusion. Proc. Natl Acad. Sci. USA 88: 9051-9055.
30. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempest P. et al. (1995) A human telomeric protein. Science 270: 1663-1667
31. Smith S. and de Lange T. (1997) TRFI, a mammalian telomeric protein. Trends Genet. 13: 21-26
32. Marcand S., Gilson E. and Shore D. (1997) A protein-counting mechanism for telomere length regulation in yeast. Science 275: 986-990
33. van Steensel B. and de Lange T. (1997) Control of telomere length by the human telomeric protein TRFI, Nature 385: 740-743
34. Cooper J. P., Nimmo E. R., Allshire R. C. and Cech T. R. (1997) Regulation of telomere length and function by a Myb-domain protein in fission yeast. Nature 385: 744-747
35. Levy M. Z., Allsopp R. C., Futcher A. B., Greider C. W. and Harley C. B. (1992) Telomere 17 end-replication problem and cell aging. J. Molec. Biol. 225: 951-960
36. Makarov V. L., Hirose Y. and Langmore J. P. (1997) Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88: 657-666
37. Allsopp R. C., Vaziri H., Patterson C., Goldstein S., Younglai E. V., Futcher A. B. et al. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89: 10114-10118
38. Yu G.-L., Bradley J. D., Attardi L. D. and Blackburn E. H. (1990) In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs, Nature 344: 126-132
39. Lundblad V. and Blackburn E. H. (1993) An alternative pathway for yeast telomere maintenance rescues estl- senescence. Cell 73: 347-360
40. Harley C. B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256: 271-282
41. Harley C. B. (1995) Telomeres and aging: fact, fancy, and the future. J. NIH Res. 7: 64-68
42. Harley C. B., Futcher A. B. and Greider C. W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460
43. Lindsey J., McGill N. I., Lindsey L. A., Green D. K. and Cooke H. J. (1991) In vivo loss of telomeric repeats with age in humuns. Mutat. Res. 256: 45-48
44. Allsopp R. C., Chang E., Kashefi-Aazam M., Rogaev E. I., Piatyszek M. A., Shay J. W. et al. (1995) Telomere shortening is associated with cell division in vitro and in vivo. Expl Cell Res. 220: 194-200
45. Wright W. E., Brasiskyte D., Piatyszek M. A. and Shay J. W. (1996) Experimental elongation of telomeres extends the lifespan of immortal × normal cell hybrids. EMBO J. 15: 1734-1741
46. Bryan T. M., Englezou A., Gupta J., Bacchetti S. and Reddel R. R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14: 4240-4248
47. Salk D., Au K., Hoeh H., Stenchver M. R. and Martin G. M. (1981) Evidence of clonal attenuation, clonal succession, and elonal expansion in mass cultures of aging Werner's syndrome skin fibroblasts. Cytogenet. Cell Genet. 30: 108-117
48. Martin G., Sprague C. and Epstein C. (1970) Replicative life-span of cultivated human cells: Effects of donors' age. tissue, and genotype. Lab. Invest. 23: 86-91
49. Kruk P. A., Rampino N. J. and Bohr V. A. (1995) DNA damage and repair in telomeres: relationship to aging. Proc. Natl Acad. Sci. USA 92: 258-262
50. Yu C.-E., Oshima J., Fu Y,-H., Wijsman E. M., Hisama F., Alisch R. et al. (1996) Positional cloning of Werner's syndrome gene. Science 272: 258-262
51. Cox R. and Masson W. K. (1978) Do radiation-induced mutants of cultured mammalian cells arise by HGPRT gene mutation or X-chromosome rearrangement? Nature 276: 629-630
52. Fukuchi K.-I., Martin G. M. and Monnat R. J. (1989) Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc. Natl Acad. Sci. USA 86: 5893-5897
53. Xing X., Lindquist M. S., Liu J., Crompton N. E. A., Kitani H., Patel T. C. et al. (1995) Low-dose-rate dependence of the phenotypic and genolypic expressions of mutagenesis by 137Cs gamma rays. Radiat, Oncol. Invest. 3: 17-28
54. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L. et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Nature 268: 1749-1753
55. Sanchez Y., Desany B. A., Jones W. J., Liu Q., Wang B. and Elledge S. J. (1996) Regulation of RAD53 by the ATM-like kinases MECI and TELI in yeast cell cycle checkpoint pathways. Science 271: 357-360
56. Blackburn E. H. (1992) Telomerases. Annu. Rev. Biochem. 61: 113-129
57. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M. B. et al. (1997) A mammalian telomerase-associated protein. Science 275: 973-977
58. 57a Feng J., Funk W. D., Wang S. S., Weinrich S. L., Avilion A. A., Chiu C.-P. et al. (1995) The RNA component of human telomerase. Science 269: 1236-1241
59. Greider C. W. (1990) Telomeres. telomerase and senescence. Bioessays 12: 363-369
60. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C. et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2014
61. Shay J. W. (1995) Aging and cancer: are telomeres and telomerase the connection? Molec. Med. Today 1: 378-384
62. Wright W. E., Piatyszek M. A., Rainey W. E., Byrd W. and Shay J. W. (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18: 173-178
63. Holt S. E., Wright W. E. and Shay J. W. (1996) Regulation of telomeraso activity in immortal cell lines. Molec. Cell. Biol. 16: 2932-2939
64. Broccoli D., Young J. W. and de Lange T. (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl Acad. Sci. USA 92: 9082-9086
65. Tahara H., Nakaishi T., Kitamoto M., Nakashio J., Shay E., Tahara E. et al. (1995) Telomerase activity in human liver tisuues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55: 2734-2736
66. Ramirez R. D., Wright W. E., Shay J. W. and Taylor R. S. (1997) Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Invest. Dermatol. 108: 113-117
67. Weng N.-P., Levine B. L., June C. H. and Hodes R. J. (1995) Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl Acad. Sci. USA 92: 11091-11094
68. Chang E. and Harley C. B. (1995) Telomere length and replicative aging in human vascular tissues. Proc. Natl Acad. Sci. USA 92: 11190-11194
69. Sharma H. W., Sokoloski J. A., Perez J. R., Maltese J. Y., Sartorelli A.C., Stein C.A. et al. (1995) Differentiation of immortal cells inhibits telomerase activity. Proc. Natl Acad. Sci. USA 92: 12343-12346
70. Blasco M. A., Rizen M., Greider C. W. and Hanahan D. (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet. 12: 200-204
71. Ames B. N., Shigenaga M. K. and Hagen T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA 90: 7915-7922
72. Votja P. A. and Barrett J. C. (1995) Genetic analysis of cellular senescence. Biochim. Biophys. Acta 1242: 29-41
73. Campisi J., Dimri G. and Hara E. (1996) Control of replicative senescence. In: Handbook of the Biology of Aging, pp. 121-149, Schneider E. L. and Rowe J. W. (eds), Academic Press, San Diego
74. Perls T. T. (1995) The oldest old. Scient. Am. 272: 70-75
75. Linskens M. H. K., Harley C. B., Campisi J. and Hayflick L. (1995) Replicative senescence and cell death. Science 267: 17
76. Hayflick L. and Moorfield P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585-621
77. Hayflick L. (1965) The limited in vitro lifetime of human diploid cell strains. Cell Res. 37: 614-636
78. Reference deleted in proofs.
79. Campisi J. (1996) Replicative senescence: an old lives' tale. Cell 84: 497-500
80. Matsumara T., Zerrudo Z. and Hayflick L. (1979) Senescent human diploid cells in culture: survival, DNA synthesis and morphology. J. Gerontol. 34: 328-334
81. Stein G. H., Drullinger L. F., Robetorye R. S., Pereira-Smith O. M. and Smith J. R. (1991) Senescent cells fail to express cdc2, cycA and cycB in response to mitogen stimulation. Proc. Natl Acad. Sci. USA 88: 11012-11016
82. Dulic V., Drullinger L. F., Lees E., Reed S. I. and Stein G. H. (1993) Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-cdk2 and cyclin D1-cdk2 complexes. Proc. Natl Acad. Sci. USA 90: 11304-11308
83. Wang E. (1995) Senescent human fibroblasts resist programmed cell death, and failure to suppress bc12 is involved. Cancer Res. 55: 2284-2292
84. Shay J. W., Wright W. E., Brasiskyte D. and van der Haegen B. A. (1993) E6 of human papillomavirus type 16 can over-come the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8: 1407-1413
85. Klingelhutz A. J., Barber S. A., Smith P. P., Dyer K. and McDougall J. K. (1994) Restoration of telomeres in human pupillomavirus-immortalized human anogenital epithelial cells. Molec. Cell. Biol. 14: 961-969
86. Counter C. M., Avilion A. A., LeFeuvre C. E., Stewart N. G., Greider C. W., Harley C. B. et al. (1992) Telomore shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11: 1921-1929
87. Wright W. E., Pereira-Smith O. M. and Shay J. W. (1989) Reversible cellular senescence: immortalization of normal human diploid fibroblasts. Molec. Cell. Biol. 9: 3088-3092
88. Alcorta D. A., Xiong Y., Phelps D., Hannon G., Beach D. and Barrett J. C. (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence. Proc. Natl Acad. Sci. USA 93: 13742-13747
89. Bond J. A., Blaydes J. P., Rowson J., Haughton M. F., Smith J. R. and Wynford-Thomas D. (1995) Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SD11 WAR. Cancer Res. 55: 2404-2409
90. Rubelj I. and Pereira-Smith O. M. (1994) SV40-transformed human cells in crisis exhibit changes that occur in normal senescence. Expl Cell Res. 211: 82-89
91. Tahara H., Sato E., Noda A. and Ide T. (1995) Increase in expression level of p21 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10: 835-840
92. Hara E., Tsurui H., Shinozaki A., Nakada S. and Oda K. (1991) Cooperative effects of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179: 528-534
93. Serrano M., Lin A. W., McCurrach M. E., Beach D. and Lowe S. W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16. Cell 88: 593-602
94. Rogan E. M., Bryan T. M., Hukku B., Maclean K., Chang A. C., Moy E. L. et al. (1995) Alterations in p53 and p16 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Molec. Cell. Biol. 15:4745-4753
95. Goldstein S. (1990) Replicative senescence: the human ribroblast comes of age. Science 249: 1129-1133
96. Metz T., Harris A. W. and Adams J. M. (1995) Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82: 29-36
97. Noda A., Ning Y., Venable S. F., Pereira-Smith O. M. and Smith J. R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Expl Cell Res. 211: 90-98
98. Deng C., Zhang P., Harper J. W., Elledge S. J. and Leder P. (1995) Mice lacking p21 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684
99. Brugarolas J., Chandrasekaran C., Gordon J. I., Beach D., Jacks T. and Hannon G. J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557
100. Kao G. D., McKenna G., Maity A., Blank K. and Muschel R. J. (1997) Cyclin B1 availability is a rate limiting componenet of the radiation-indiced G2 delay in HeLa cells. Cancer Res. 57: 753-758
101. Serrano M., Lee H.-W., Chin L., Cordon-Cardo C., Beach D. and DePinho R. A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37
102. Lowe S., Schmitt E. M., Smith S. W., Osborne B. A. and Jacks T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
103. Weinberg R. A. (1997) The cat and mouse games that genes, viruses, and cells play. Cell 88: 573-575
104. Walburg H. E. (1975) Radiation-induced life-shortening and premature aging. Adv. Radiat. Biol. 5: 145-179
105. Haber D. A. (1995) Telomeres, cancer, and immortality. New Engl. J. Med. 332: 955-956